Plasma and cerebrospinal Reelin concentrations are generally reported to be reduced in ASD and schizophrenia but variably altered in Alzheimer's disease (Impagnatiello et al., 1998; Joly-Amado et al., 2023). The gene discussed is RELN; the disease is early-onset autosomal dominant Alzheimer disease.